PGCM
NEO icon

Prescott Group Capital Management’s NeoGenomics NEO Stock Holding History

Prescott Group Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,000
Closed -$292K – 250
2025
Q2 		$292K Buy
+40,000
New +$323K 0.03% 234

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Prescott Group Capital Management's NEO Position: Q3 2025 in Review

Prescott Group Capital Management sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 40,000 shares — an estimated $292K sold.

Prescott Group Capital Management first reported a position in NEO in Q2 2025 and held it in 1 quarter. The position peaked at $292K in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Prescott Group Capital Management reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
  • Prescott Group Capital Management sold 40,000 NeoGenomics shares in Q3 2025, an estimated $292K.
  • Prescott Group Capital Management first reported a position in NeoGenomics in Q2 2025 and held it in 1 quarter.
  • Prescott Group Capital Management's NeoGenomics position peaked at $292K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Prescott Group Capital Management's 13F filing for Q3 2025, filed 6 Nov 2025.